Ruth Langley

I am based at the UK Medical Research Council Clinical Trials Unit at University College London where I jointly lead the Cancer Group; and have a clinical consultant post at the Brighton and Sussex University Hospital.

I have a particular interest in gastro-oesophageal malignancy and have co-ordinated a series of trials and associated translational studies, and have led the investigation of the use of transdermal oestrogen in the treatment of prostate cancer.

I am the Chief Investigator of an international trial (Add-Aspirin) designed to assess the effect of aspirin as an additional adjuvant agent in several common solid tumours.